# Vanderbilt University Medical Center: Phase 1 study terminated, 34 enrolled (Autonomic Failure, Pure Autonomic Failure)

**Score:** 50/100

| Field | Value |
|---|---|
| Sponsor | Vanderbilt University Medical Center |
| Sponsor type | Academic and hospital |
| Study | Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure |
| NCT ID | NCT02897063 |
| Phase | Phase 1 |
| Status | terminated |
| Conditions | Autonomic Failure; Pure Autonomic Failure; Multiple System Atrophy; Parkinson Disease; Orthostatic Hypotension |
| Intervention types | drug |
| Target enrollment | 34 |
| Site countries | United States |
| Posted | 2016-09-12 |
| Planned start | 2016-09 |
| Event | Terminated |
| Event date | 2026-10 |
| Last update posted | 2026-10-23 |

## Why this score
- Posted in the last two weeks.
- Stopped early: budget and sites freed up.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT02897063). Last refreshed: 2026-11-05T08:46:16.625Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.